HCA Healthcare, Inc. (HCA) 의 후행 P/E는 17.2, 선행 P/E 16.1. 후행 이익수익률은 5.80%, 선행 이익수익률 6.20%. PEG 0.59 (Peter Lynch 저평가 ≤1.0).
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 61/100 5/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 9.5 | 0.21 | -3.76 | 0.66 | - |
| 2017 | 13.9 | -0.74 | -4.52 | 0.71 | - |
| 2018 | 11.3 | 0.15 | -8.62 | 0.91 | 1.14% |
| 2019 | 14.4 | -2.06 | -17.96 | 0.98 | 1.09% |
| 2020 | 14.9 | 1.89 | 97.59 | 1.08 | 0.27% |
| 2021 | 11.9 | 0.13 | -89.03 | 1.41 | 0.75% |
| 2022 | 12.3 | -1.28 | -25.18 | 1.16 | 0.94% |
| 2023 | 14.1 | -13.67 | -41.56 | 1.13 | 0.90% |
| 2024 | 13.5 | 0.86 | -31.06 | 1.10 | 0.89% |
| 2025 | 15.9 | 0.56 | -17.87 | 1.42 | 0.63% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $7.30 | $41.49B | $2.89B | 7% |
| 2017 | $5.95 | $43.61B | $2.22B | 5.1% |
| 2018 | $10.66 | $46.68B | $3.79B | 8.1% |
| 2019 | $10.07 | $51.34B | $3.51B | 6.8% |
| 2020 | $10.93 | $51.53B | $3.75B | 7.3% |
| 2021 | $21.16 | $58.75B | $6.96B | 11.8% |
| 2022 | $19.15 | $60.23B | $5.64B | 9.4% |
| 2023 | $18.96 | $64.97B | $5.24B | 8.1% |
| 2024 | $22.00 | $70.6B | $5.76B | 8.2% |
| 2025 | $28.38 | $75.6B | $6.78B | 9% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $30.27 | $29.18 – $31.41 | $78.6B | $77.14B – $80.09B | 16 |
| 2027 | $33.30 | $32.20 – $34.43 | $82.38B | $81.15B – $84.38B | 16 |
| 2028 | $37.30 | $35.61 – $38.71 | $86.9B | $86.76B – $87.04B | 7 |
| 2029 | $42.58 | $41.58 – $43.93 | $92.67B | $91B – $94.93B | 2 |
| 2030 | $49.36 | $48.21 – $50.93 | $100.42B | $98.61B – $102.86B | 5 |
